Listed

Nortech Systems Inc: Form 10-Q for the period ended Mar 31, 2017

Filed with the SEC on May 11, 2017 and accepted by EDGAR at May 11, 2017, 16:12 ET.

Share

Management's discussion and analysis

As filed, 15,869 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Overview

We are a Maple Grove, Minnesota based full-service electronics manufacturing services (“EMS”) contract manufacturer of wire and cable assemblies, printed circuit board assemblies, higher-level assemblies and box builds for a wide range of industries. We provide value added engineering services and technical support including design, testing, prototyping and supply chain management to customers mainly in the aerospace and defense, medical, and industrial equipment markets. We maintain facilities in Bemidji, Blue Earth, Eden Prairie, Mankato, Merrifield, and Milaca, Minnesota; Monterrey, Mexico; and Suzhou, China. All of our facilities are certified to one or more of the ISO/AS standards, including 9001, AS9100 and 13485, with most having additional certifications based on the needs of the customers they serve.

2017 First Quarter Highlights

The first quarter of 2017 revenue was $28.3 million, compared to revenue of $28.9 in first quarter of prior year. Medical market revenue increased $2.1 million or 18.0% from prior year with our defense revenue down by $0.5 million or 12.1% and industrial revenue down $2.3 million or 17.1%. The first quarter revenue softness was expected due to the lower backlog to start the year as our customers adjusted to their demand. Heading into the second quarter, our backlog at March 31, 2017 has rebounded nicely and is up 14.5% from the start of the year and 15.9% compared to the prior year.

Our first quarter 2017 gross margin of $3.1 million or 10.9% of sales was down $0.3 million and 80 basis points from the prior year. Plant utilization was down, and closing costs associated with the Augusta plant closing and product transfer costs impacted the gross margin in the quarter.

Operating profit for the first quarter of 2017 was $0.1 million as compared to $0.2 million for the prior year’s first quarter. A $354,000 gain from the sale of the Augusta facility was offset by the lower gross margin and increases in general and administrative expenses for professional service fees, investments in information systems resources and our new China operations.

Net loss for the three months ended March 31, 2017 was $14,700 or ($0.01) per basic and diluted common share, compared to net income for the three months ended March 31, 2016 of $62,900 or $0.02 per basic and diluted common share.

Results of Operations

The following table presents statements of operations data as percentages of total net sales for the periods indicated:

Three Months Ended March 31 2017 2016
Net Sales 100.0% 100.0%
Cost of Goods Sold 89.1 88.3
Gross Profit 10.9 11.7
Selling Expenses 4.3 4.5
General and Administrative Expenses 7.5 6.4
Gain on Sale of Property and Equipment (1.3) 0.0
Income from Operations 0.4 0.8
Other Expenses, Net (0.5) (0.5)
Income (Loss) Before Income Taxes (0.1) 0.3
Income Tax Expense (Benefit) (0.0) 0.1
Net Income (Loss) (0.1)% 0.2%

Net Sales

Net sales was $28.3 million in the first quarter of 2017, as compared to $28.9 million in the first quarter of the prior year, a decrease of $0.6 million or 2.2%. Net sales results were varied by markets, the medical market increased by $2.1 million or 18.0% with medical component products accounting for 84.0% of the increase and medical devices the remaining 16.0%. The industrial market sector was down $2.3 million in the first quarter of 2017 as compared to the same quarter of 2016, primarily from lower demand levels from our transportation equipment customers. Net sales from the aerospace and defense markets decreased by 12.1% in the first quarter of 2017 as compared to the first quarter of 2016 due to lower customer orders.

Net sales by our major EMS industry markets for the three month periods ended March 31, 2017 and 2016 were as follows:

Three Months Ended March 31
2017 2016%
(in thousands) $$ Change
Aerospace and Defense 3,351 3,811 (12.1)
Medical 13,858 11,745 18.0
Industrial 11,109 13,394 (17.1)
Total Sales 28,318 28,950 (2.2)

Backlog

Our 90-day order backlog as of March 31, 2017 was $23.5 million, a 14.5% increase from the beginning of the quarter and a 15.9% increase as compared to the prior year. Backlog for our medical customers has increased 33.6% over the prior year and 10.4% over the prior quarter. The aerospace and defense backlog increased 13.3% from the beginning of the quarter and decreased 22.7% from the prior year as past due orders were reduced significantly. Our industrial customers’ backlog increased 22.8% from the beginning of the quarter and 24.0% from the prior year, improving our position heading into the second quarter. Our backlog consists of firm purchase orders and we expect a major portion of the current 90 day backlog to be realized as revenue during the following quarter.

90 day backlog by our major EMS industry markets are as follows:

(in thousands)

Backlog as of the Quarter Ended March 31 2017 December 31 2016 March 31 2016
Aerospace and Defense $4,122 $3,637 $5,334
Medical 11,917 10,799 8,922
Industrial 7,418 6,042 5,980
Total Backlog $23,457 $20,478 $20,236

Our 90 day backlog varies due to order size, manufacturing delays, contract terms and conditions and timing from customer delivery schedules and releases. These variables cause inconsistencies in comparing the backlog from one period to the next.

Gross Profit

Gross profit as a percent of net sales for the three months ended March 31, 2017 and 2016, was 10.9% and 11.7%, respectively. The decrease in gross profit in the first quarter of 2017 as compared to the same period last year was due to lower plant utilization, closing costs associated with the Augusta plant shut down and product transfer costs.

Selling Expense

Selling expense for the three months ended March 31, 2017 and 2016 was $1.2 million or 4.3% of sales and $1.3 million or 4.5% of sales, respectively. The decrease is due to the timing of expenses. We expect to continue at an increased rate of funding for business development activities and marketing initiatives to maintain existing business and stimulate sales growth.

General and Administrative Expense

General and administrative expenses for the three months ended March 31, 2017 and 2016, were $2.1 million or 7.5% of sales and $1.9 million or 6.4% of sales, respectively. The increase in general and administrative expense for the periods listed was due to an increase in professional service fees, investments in information systems resources and our new China operations.

Gain from Sale of Property and Equipment

Net gain from sale of property and equipment for the quarter ended March 31, 2017 was $354,000 from the sale of the Augusta building and building improvements (see Note 6). There was no gain from sale of property and equipment recorded in 2016.

Income from Operations

First quarter 2017 income from operations was $120,000 as compared to $221,000 for the first quarter in 2016. The decline in income from operations of $100,000 for the quarter was due to the lower gross margin impact and increased general and administrative expenses.

Income Taxes

On a quarterly basis, we estimate what our effective tax rate will be for the full fiscal year and record a quarterly income tax provision based on the anticipated rate. As the year progresses, we refine our estimate based on the facts and circumstances, including discrete events, by each tax jurisdiction. Our effective tax rate for the three months ended March 31, 2017 and 2016 was 23.3% and 29.2%, respectively. The effective tax rate for the year ended December 31, 2017 is expected to be 23.3% compared to 44.4% for the year ended December 31, 2016. The decrease is due mainly to the higher level of income expected in China and related foreign tax rate differential benefit.

Net Income (Loss)

Net loss for the three months ended March 31, 2017 was $14,700 or ($0.01) per basic and diluted common share, compared to net income for the three months ended March 31, 2016 of $62,900 or $0.02 per basic and diluted common share.

Liquidity and Capital Resources

Net cash used in operating activities for the three months ended March 31, 2017 was $255,000. The noncash addback of depreciation and amortization along with increases in accounts payable, through the extension of terms and conditions, has positively impacted cash flows, offset by a gain on disposal of property and equipment and an increase in inventory.

Net cash provided by investing activities of $370,000 for the three months ended March 31, 2017, was generated from the proceeds of the sale of the Augusta building (see Note 6), offset by property and equipment purchases to support the business.

We have satisfied our liquidity needs over the past several years with cash flows generated from operations and an operating line of credit through WFB. We also have real estate and equipment term loans. We have a credit agreement with WFB which was most recently amended on January 12, 2017 and provides for a line of credit arrangement of $15.0 million that expires, if not renewed, on May 31, 2018. The credit arrangement also has a $1.8 million real estate term note outstanding with a maturity date of March 31, 2027, an additional $1.7 million real estate term note outstanding that is due, if not renewed, on December 31, 2027, an equipment loan for $2.7 million and a term loan facility of up to $1.0 million for capital expenditures, both with maturity dates of May 31, 2018.

Both the line of credit and real estate term notes are subject to fluctuations in the LIBOR rates. The line of credit, real estate term notes, and equipment loans with WFB contain certain covenants which, among other things, require us to adhere to regular reporting requirements, abide by annual shareholder dividend limitations, maintain certain financial performance, and limit the amount of annual capital expenditures. The availability under our line is subject to borrowing base requirements, and advances are at the discretion of the lender. The line of credit is secured by substantially all of our assets.

On March 31, 2017, we had outstanding advances of $8.1 million under the line of credit and unused availability of $4.9 million supported by our borrowing base. We believe our financing arrangements and cash flows to be provided by operations will be sufficient to satisfy our future working capital needs. Our working capital was $19.5 and $19.2 million as of March 31, 2017 and December 31, 2016, respectively.

Our credit agreement with WFB requires us to maintain a minimum fixed charge coverage ratio of not less than 1.05 to 1.00. The fixed charge coverage ratio at March 31, 2017 was 1.43 to 1.00.

Cash conversion cycle:

Three Months Ended March 31, 2017 March 31, 2016
Days in trade accounts receivable 54 53
Days in inventory 78 76
Days in accounts payable (54) (46)
Cash conversion cycle 78 83

18

We calculate days in accounts receivable as accounts receivable for the respective quarter divided by annualized sales for the respective quarter by day. We calculate days in inventory and accounts payable as each balance sheet line item for the respective quarter divided by annualized cost of sales for the respective quarter by day. We calculate cash conversion cycle as the sum of days in receivable and inventory less days in accounts payable. Items which may cause the cash conversion cycle in a particular period to differ include, but are not limited to, changes in business mix, changes in payment terms and the timing of revenue recognition and inventory purchases within the period. Days in accounts accounts payable for the three months ended March 31, 2017 increased by eight days compared to the three months ended March 31, 2016, as a result of the timing of payments. The improvements were partially offset by an increase in days in accounts receivable as a result of timing of collections and an increase in days in inventory which was caused by increased inventory on hand related to delays in shipments, delays in new product launches, product transfer safety stock and projects on hold for customer design issues.

Off-Balance Sheet Arrangements

We have not engaged in any off-balance sheet activities as defined in Item 303(a)(4) of Regulation S-K.

Critical Accounting Policies and Estimates

Our significant accounting policies and estimates are summarized in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2016. There have been no significant changes in these critical accounting policies since December 31, 2016. Some of our accounting policies require us to exercise significant judgment in selecting the appropriate assumptions for calculating financial estimates. Such judgments are subject to an inherent degree of uncertainty. These judgments are based on our historical experience, known trends in our industry, terms of existing contracts and other information from outside sources, as appropriate. Actual results could differ from these estimates.

Forward-Looking Statements

Those statements in the foregoing report that are not historical facts are forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements generally will be accompanied by words such as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “possible,” “potential,” “predict,” “project,” or other similar words that convey the uncertainty of future events or outcomes. Although we believe these forward-looking statements are reasonable, they are based upon a number of assumptions concerning future conditions, any or all of which may ultimately prove to be inaccurate. Forward-looking statements involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from the forward-looking statements include, without limitation:

  • Volatility in the marketplace which may affect market supply and demand for our products;
  • Increased competition;
  • Changes in the reliability and efficiency of operating facilities or those of third parties;
  • Risks related to availability of labor;
  • Increase in certain raw material costs such as copper;
  • Commodity and energy cost instability;
  • Dependence on certain customers;
  • Possible customer cancellations of orders, impact of financial difficulty of customers and other factors that could cause losses relating to customer orders;
  • General economic, financial and business conditions that could affect our financial condition and results of operations; and
  • Availability of raw material components.

The factors identified above are believed to be important factors (but not necessarily all of the important factors) that could cause actual results to differ materially from those expressed in any forward-looking statement made by us. Unpredictable or unknown factors not discussed herein could also have material adverse effects on forward-looking statements. All forward-looking statements included in this Form 10-Q are expressly qualified in their entirety by the forgoing cautionary statements. We undertake no obligations to update publicly any forward-looking statement (or its associated cautionary language) whether as a result of new information or future events.

Please refer to forward-looking statements and risks as previously disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.

Controls and procedures

As filed, 1,458 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

In accordance with Rule 13a-15(b) of the Securities Exchange Act of 1934 (the “Exchange Act”), as of the end of the period covered by this Quarterly Report on Form 10-Q, our management evaluated, with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act). These controls and procedures are designed to ensure that information required to be disclosed in the Company’s Exchange Act reports is (1) recorded, processed, summarized and reported in a timely manner, and (2) accumulated and communicated to management, including the Company’s Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Based upon their evaluation of these disclosure controls and procedures as of the date of the evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the disclosure controls and procedures were effective.

Changes in Internal Control Over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue3 months2017-01-01 to 2017-03-31$25.2mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2017-01-01 to 2017-03-31$3.1mus-gaap:GrossProfit
Operating income3 months2017-01-01 to 2017-03-31$120.4kus-gaap:OperatingIncomeLoss
Interest expense3 months2017-01-01 to 2017-03-31$139.5kus-gaap:InterestExpense
Income tax3 months2017-01-01 to 2017-03-31−$4.4kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2017-01-01 to 2017-03-31−$14.7kus-gaap:NetIncomeLoss
Diluted EPS3 months2017-01-01 to 2017-03-31−$0.01us-gaap:EarningsPerShareDiluted
Basic EPS3 months2017-01-01 to 2017-03-31−$0.01us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2017-01-01 to 2017-03-312,747,831 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Capital expenditure3 months2017-01-01 to 2017-03-31$198.2kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2017-03-31$205.5kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-03-31$40.3mus-gaap:AssetsCurrent
Total assetsAt period end2017-03-31$55.8mus-gaap:Assets
Current liabilitiesAt period end2017-03-31$20.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-03-31$33.5mus-gaap:Liabilities
Long-term debtAt period end2017-03-31$4.0mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2017-03-31$1.6mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2017-03-31$22.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001104659-17-031905. Last ingested by Listed: Nov 12, 2026, 19:20 ET. Listed shows no prices and gives no investment advice.